Intra-cornu ammonis 1 administration of the human immunodeficiency virus-1 protein trans-activator of transcription exacerbates the ethanol withdrawal syndrome in rodents and activates N-methyl-d-aspartate glutamate receptors to produce persisting spatial learning deficits

Neuroscience

Volumn 163, Issue 3, 2009, Pages 868-876

  Self, R L ^a,b   Smith, K J ^a,b   Butler, T R ^a,b   Pauly, J R ^a,b   Prendergast, M A ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

AIDS; alcoholism; hippocampus; HIV associated dementia; memory; substance abuse

Indexed keywords

ALCOHOL; BENZODIAZEPINE RECEPTOR; DIZOCILPINE; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; TRANSACTIVATOR PROTEIN; WATER;

ALCOHOL BLOOD LEVEL; ALCOHOL WITHDRAWAL; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CANNULA; COGNITIVE DEFECT; CONTROLLED STUDY; ENCEPHALITIS; ENZYME ACTIVATION; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VIVO STUDY; LEARNING DISORDER; MALE; MAZE TEST; MICROGLIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PYRAMIDAL NERVE CELL; RAT; RECEPTOR DENSITY; RODENT; SEIZURE; TISSUE SECTION; TREMOR;

ANIMALS; AUTORADIOGRAPHY; DIZOCILPINE MALEATE; ETHANOL; HIPPOCAMPUS; INJECTIONS, INTRAVENTRICULAR; ISOQUINOLINES; MALE; MAZE LEARNING; MICROGLIA; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; SPATIAL BEHAVIOR; SUBSTANCE WITHDRAWAL SYNDROME; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 70249112936     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.07.025     Document Type: Article

References (51)

1. Acheson S.K., Richardson R., and Swartzwelder H.S. Developmental changes in seizure susceptibility during ethanol withdrawal. Alcohol 18 1 (1999) 23-26
2. Bagby G.J., Stoltz D.A., Zhang P., Kolls J.K., Brown J., Bohm Jr. R.P., Rockar R., Purcell J., Murphey-Corb M., and Nelson S. The effect of chronic binge ethanol consumption on the primary stage of SIV infection in rhesus macaques. Alcohol Clin Exp Res 27 3 (2003) 495-502
3. Behnisch T., Francesconi W., and Sanna P. HIV secreted protein Tat prevents long-term potentiation in the hippocampal CA1 region. Brain Res 1012 (2004) 187-189
4. Carpenter-Hyland E.P., Woodward J.J., and Chandler L.J. Chronic ethanol induces synaptic but not extrasynaptic targeting of NMDA receptors. J Neurosci 24 (2004) 7859-7868
5. Casellas P., Galiegue S., and Basile A.S. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 40 (2002) 478-486
6. Chizh B.A., Headley P.M., and Tzschentke T.M. NMDA receptor antagonists as analgesics: focus on the NR2B subtype. Trends Pharmacol Sci 22 (2001) 636-642
7. Collins M.A., Corso T.D., and Neafsey E.J. Neuronal degeneration in rat cerebrocortical and olfactory regions during subchronic "binge" intoxication with ethanol: possible explanation for olfactory deficits in alcoholics. Alcohol Clin Exp Res 20 (1996) 284-292
8. 3H]PK11195 binding in relation to imidazoline-I2-receptor and alpha 2-adrenoceptor binding in the hippocampus following transient global forebrain ischaemia in the rat. Neuroscience 82 3 (1998) 805-817
9. Crews F.T., Braun C.J., Hoplight B., Switzer III R.C., and Knapp D.J. Binge ethanol consumption causes differential brain damage in young adolescent rats compared with adult rats. Alcohol Clin Exp Res 24 (2000) 1712-1723
10. Dubois A., Bénavidès J., Peny B., Duverger D., Fage D., Gotti B., MacKenzie E.T., and Scatton B. Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat. Brain Res 445 1 (1988) 77-90
11. Ensoli B., Buonaguro L., Barillari G., Fiorelli N., Gendelman R., Morgan R.A., Wingfield P., and Gallo R. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol 67 (1993) 277-287
12. Fada F., and Rossetti Z.L. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 56 (1998) 385-431
13. Galvan F.H., Bing E.G., Fleishman J.A., London A.S., Caetano R., Burnam M.A., Longshore D., Morton S.C., Orlando M., and Shapiro M. The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study. J Stud Alcohol 62 (2002) 179-186
14. Garcia-Martinez L.F., Mavankal G., Neveu J.M., Lane W.S., Ivanov D., and Gaynor R.B. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J 16 (1997) 2836-2850
15. Green J.E., Saveanu R.V., and Bornstein R.A. The effect of previous alcohol abuse on cognitive function in HIV infection. Am J Psychiatry 161 (2004) 249-254
16. Haughey N.J., Nath A., Mattson M.P., Slevin J.T., and Geiger J.D. HIV-1 Tat through phosphorylation of NMDA receptors potentiates glutamate excitotoxicity. J Neurochem 78 (2001) 457-467
17. Itzhak Y., Baker L., and Norenberg M.D. Characterization of the peripheral-type benzodiazepine receptors in cultured astrocytes: evidence for multiplicity. Glia 9 (1993) 211-218
18. Janssen E.S., Wanyanwn O.C., Selik R.M., and Stehr-Green J.K. Epidemiology of human immunodeficiency encephalopathy in the United States. Neurology 42 (1992) 1472-1476
19. King J.E., Eugenin E.A., Buckner C.M., and Berman J.W. HIV tat and neurotoxicity. Microbes Infect 8 (2006) 1347-1357
20. Kumari M., and Anji A. A novel RNA binding protein that interacts with NMDA R1 mRNA: regulation by ethanol. Eur J Neurosci 23 (2006) 2339-2350
21. Lange J.E., and Voas R.B. Defining binge drinking quantities through resulting blood alcohol concentrations. Psychol Addict Behav 15 (2001) 310-316
22. Lefevre F., O'Leary B., Moran M., Mossar M., Yarnold P.R., Martin G.J., and Glassroth J. Alcohol consumption among HIV-infected patients. J Gen Intern Med 10 (1995) 458-460
23. Li S.T., Matsushita M., Moriwaki A., Saheki Y., Lu Y.F., Tomizawa K., Wu H.Y., Terada H., and Matsui H. HIV-1 Tat inhibits long-term potentiation and attenuates spatial learning. Ann Neurol 55 (2004) 362-371
24. Ma M., and Nath A. Molecular determinants for cellular uptake of tat protein of human immunodeficiency virus type 1 in brain cells. J Virol 71 (1997) 2495-2499
25. Majchrowicz E. Induction of physical dependence upon ethanol and the associated behavioral changes. Psychopharmacologia 43 (1975) 245-254
26. Martens U., Capito B., and Wree A. Septotemporal distribution of [3H]MK-801, [3H]AMPA and [3H]Kainate binding sites in the rat hippocampus. Anat Embroyol 198 3 (1998) 195-204
27. McArthur J.C., Hoover D.R., Bacellar H., Miller E.N., Cohen B.A., Becker J.T., Graham N.M., McArthur J.H., Selnes O.A., and Jacobson L.P. Dementia in AIDS patients. Neurology 43 (1993) 2245-2252
28. Morris R.G.M. Spatial localisation does not depend on the presence of local cues. Learn Motiv 12 (1981) 239-260
29. 3H]PK 11195 binding in rat cerebral cortex following a local ischaemic lesion. J Cereb Blood Flow Metab 11 (1991) 314-322
30. Nath A. Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186 Suppl 2 (2002) S193-S198
31. Nixon K., and Crews F.T. Binge ethanol exposure decreases neurogenesis in adult rat hippocampus. J Neurochem 83 5 (2002) 1087-1093
32. 11C]PK1195. Neurology 55 (2000) 1052-1054
33. Pauly J.R., and Collins A.C. An autoradiographic analysis of nicotinic cholinergic receptors following chronic corticosterone treatment. Neuroendocrinology 57 (1993) 262-271
34. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press, San Diego
35. Perkins H.W., DeJong W., and Linkenbach J. Estimated blood alcohol levels reached by "binge" and "nonbinge" drinkers: a survey of young adults in Montana. Psych Addict Behav 15 (2001) 317-320
36. Pfefferbaum A., Rosenbloom M.J., Rohlfing T., Adalsteinsson E., Kemper C.A., Deresinski S., and Sullivan E.V. Contribution of alcoholism to brain dysmorphology in HIV infection: effects on the ventricles and corpus callosum. Neuroimage 33 1 (2006) 239-251
37. Pocernich C.B., Boyd-Kimball D., Poon H.F., Thongboonkerd V., Lynn B.C., Klein J.B., Calebrese V., Nath A., and Butterfield D.A. Proteomics analysis of human astrocytes expressing the HIV protein Tat. Brain Res Mol Brain Res 133 (2005) 307-316
38. Pocernich C.B., Poon H.F., Boyd-Kimball D., Lynn B.C., Nath A., Klein J.B., and Butterfield D.A. Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat. Brain Res Mol Brain Res 133 (2005) 299-306
39. Prendergast M.A., Rogers D.T., Mulholland P.J., Littleton J.M., Wilkins Jr. L.H., Self R.L., and Nath A. Neurotoxic effects of the human immunodeficiency virus type-1 transcription factor Tat require function of a polyamine site on the N-methyl-d-aspartate receptor. Brain Res 954 (2002) 300-307
40. Rothlind J.C., Greenfield T.M., Bruce A.V., Meyerhoff D.J., Flenniken D.L., Lindgren J.A., and Weiner M.W. Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance. J Int Neuropsychol Soc 11 (2005) 70-83
41. Rudolph J.G., Walker D.W., Imuro Y., Thurman R.G., and Crews F.T. NMDA receptor binding in adult rat brain after several chronic ethanol treatment protocols. Alcohol Clin Exp Res 21 (1997) 1508-1519
42. Samet J.H., Horton N.J., Traphagen E.T., Lyon S.M., and Freedberg K.A. Alcohol consumption and HIV disease progression: are they related?. Alcohol Clin Exp Res 27 (2003) 862-867
43. Sardar A.M., Hutson P.H., and Reynolds G.P. Deficits of NMDA receptors and glutamate uptake sites in the frontal cortex in AIDS. Neuroreport 10 (1999) 3513-3515
44. Schiffito G., Navia B.A., Yiannoutsos C.T., Marra C.M., Chang L., Ernst T., Jarvik J.G., Miller E.N., Singer E.J., Ellis R.J., Kolson D.L., Simpson D., Nath A., Berger J., Shriver S.L., Millar L.L., Colquhoun D., Lenkinksi R., Gonzalez R.G., Lipton S.A., and Adult AIDS Clinical Trial Group (ACTG) 301; 700 Teams; HIV MRS Consortium. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS 21 (2007) 1877-1886
45. Self R.L., Mulholland P.J., Nath A., and Prendergast M.A. Cytotoxic effects of exposure to the human immunodeficiency virus type 1 protein Tat in the hippocampus are enhanced by prior ethanol treatment. Alcohol Clin Exp Res 28 (2004) 1916-1924
46. Shibata N., Kageyama M., Kishida T., Kimura K., Yoshikawa Y., Kuwahara T., Toh J., Shirasaka T., and Takada K. Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats. Biopharm Drug Dispos 24 8 (2003) 335-344
47. Suvarna N., Borgland S.L., Wang J., Phamluong K., Auberson Y.P., Bonci A., and Ron D. Ethanol alters trafficking and functional N-methyl-D-aspartate receptor NR2 subunit ration via H-Ras. J Biol Chem 280 (2005) 31450-31459
48. Tabakoff B. Alcohol and AIDS-is the relationship all in our heads?. Alcohol Clin Exp Res 18 (1994) 415-416
49. Tyor W.R., and Middlaugh L.D. Do alcohol and cocaine abuse alter the course of HIV-associated dementia complex. J Leukoc Biol 65 (1999) 475-481
50. Wang P., Barks J.D., and Silverstein F.S. Tat, a human immunodeficiency virus-1-derived protein augments excitotoxic hippocampal injury in neonatal rats. Neuroscience 88 (1999) 585-597
51. Witte M.H., Borgs P., Way D.L., Ramirez Jr. G., Witte C.L., and Bernas M.J. AIDS, alcohol, endothelium, and immunity. Alcohol 11 (1994) 91-97